J. Goldman & CO LP Spring Works Therapeutics, Inc. Transaction History
J. Goldman & CO LP
- $3.21 Billion
- Q3 2024
A detailed history of J. Goldman & CO LP transactions in Spring Works Therapeutics, Inc. stock. As of the latest transaction made, J. Goldman & CO LP holds 63,236 shares of SWTX stock, worth $2.37 Million. This represents 0.06% of its overall portfolio holdings.
Number of Shares
63,236
Previous 225,934
72.01%
Holding current value
$2.37 Million
Previous $8.51 Million
76.19%
% of portfolio
0.06%
Previous 0.26%
Shares
3 transactions
Others Institutions Holding SWTX
# of Institutions
238Shares Held
69.8MCall Options Held
144KPut Options Held
257K-
Vanguard Group Inc Valley Forge, PA6.71MShares$251 Million0.0% of portfolio
-
Black Rock Inc. New York, NY5.62MShares$210 Million0.0% of portfolio
-
Deep Track Capital, LP Greenwich, CT3.84MShares$144 Million4.54% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.52MShares$132 Million0.01% of portfolio
-
Boxer Capital, LLC San Diego, CA3.42MShares$128 Million5.82% of portfolio
About SpringWorks Therapeutics, Inc.
- Ticker SWTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,401,100
- Market Cap $2.34B
- Description
- SpringWorks Therapeutics, Inc. acquires, develops, and commercializes medicines for underserved patient populations suffering from rare diseases and cancer. Its lead product candidate is nirogacestat, an oral small molecule gamma secretase inhibitor that is in Phase III clinical trial for the treatment of desmoid tumors. The company is also deve...